[Changes of biochemical blood parameters under conditions of treatment with vaulen and polysorb enterosorbents].
Alteration of the biochemical blood indices has been studied in patients with rheumatoid arthritis and lupus erythematosus that were treated with vaulen (V) and polysorb (P) enterosorbents. It was determined that alanine aminotransferase activity grew and albumin, urea, uric acid levels enhanced after the V treatment. Glucose level and alanine-, asparagine aminotransferases activities decreased after the P treatment. It is necessary to take into consideration these results when choosing an enterosorbent for treatment of patients with the immunocomplex rheumatic diseases accompanied by the liver parenchyma lesion and hyperuricemia.
Iaremenko
O B
OB
Ter-Vartan'ian
S Kh
SKh
Lopushenko
L G
LG
Mikhal'chuk
H A
HA
D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000628:therapy*; D001786:Blood Glucose / Q000378:metabolism; D016022:Case-Control Studies; D002606:Charcoal / Q000627:therapeutic use*; D016061:Enterosorption; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000628:therapy*; D008875:Middle Aged; D011108:Polymers / Q000627:therapeutic use*; D012709:Serum Albumin / Q000378:metabolism; D000637:Transaminases / Q000097:blood; D014508:Urea / Q000097:blood; D014527:Uric Acid / Q000097:blood
D001786:Blood Glucose; D011108:Polymers; D012709:Serum Albumin; C070442:vaulen; C048851:polysorb; D002606:Charcoal; D014527:Uric Acid; D014508:Urea; D000637:Transaminases; D000410:Alanine Transaminase; C022636:serine-glyoxylate aminotransferase
Zmina biokhimichnykh pokaznykiv krovi za umov vykoristannia enterosorbentiv vaulenu ta polisorbu.